Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-04-17

FDA Approved: FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE — Original Application (Aurohealth LLC)

View source ↗

Summary

FDA approved the original ANDA for a generic fixed-dose combination of fexofenadine hydrochloride and pseudoephedrine hydrochloride (Aurohealth LLC).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fexofenadine hydrochloride and pseudoephedrine hydrochloride (fexofenadine hydrochloride and pseudoephedrine hydrochloride)

Snippet

ORIG AP for FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE (FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE)